Back to Journals » Vascular Health and Risk Management » Volume 4 » Issue 5

The development of abdominal aortic aneurysms in mice is enhanced by benzo(a)pyrene

Authors Zhang Y, Ramos KS

Published 10 October 2008 Volume 2008:4(5) Pages 1095—1102

DOI https://doi.org/10.2147/VHRM.S3038

Review by Single anonymous peer review

Peer reviewer comments 2



Yong Zhang1, Kenneth S Ramos1,2

1Department of Biochemistry and Molecular Biology, University of Louisville School of Medicine, Louisville, KY, USA; 2Center for Genetics and Molecular Medicine, University of Louisville, Louisville, KY, USA

Abstract: Cigarette smoking has been strongly associated with abdominal aortic aneurysm (AAA), but the components of tobacco smoke involved in AAA have not been identified. Benzo(a)pyrene (BaP) is an important constituent in cigarette smoke capable of induction of alterations strikingly similar to the pathological changes seen during AAA development. We therefore hypothesized that BaP exposure contributes to the development of AAA. In this study, C57/B6J mice were treated with vehicle, angiotensin II (AngII) (0.72 mg/kg/day), BaP (10 mg/kg/week), or the combination of AngII and BaP, for 5 weeks, and then examined for incidence of AAA and pathological changes of the aortic wall. Results showed that incidence of AAA formation in C57/B6J mice treated with BaP and AngII was significantly higher than that in AngII-treated mice (7 of 12 compared to 2 of 12). Further, five mice in the group treated with AngII/BaP and one in the group treated with AngII exhibited AAA rupture and hematoma. BaP caused macrophage infi ltration, disarray of elastic lamella, and loss of vascular smooth muscle cells (VSMCs). We conclude that BaP aggravates AAA formation and rupture in C57/B6J mice by promoting macrophage infi ltration, degeneration of elastic lamella, and loss of VSMCs in the aortic wall.

Keywords: abdominal aortic aneurysm, benzo(a)pyrene, cigarette smoking, aorta, C57B/6J mice

Creative Commons License © 2008 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.